NorthEdge invests in life sciences marketing agency ramarketing
The investment comes from NorthEdge’s £125M SME fund.
Private equity firm NorthEdge has completed its investment in life sciences marketing agency ramarketing, which will support an expansion of the firm's services and increased international presence.
Ramarketing is a full-service marketing firm that supports clients in the pharmaceutical and biotech industries. According to the company, it is regarded as one of the fastest-growing life sciences agencies in the world.
NorthEdge’s investment will help ramarketing to increase the range of services it offers and further expand its US footprint, building on its presence in Boston, MA.
Raman Sehgal, founder and Global President of ramarketing, said this marks a new chapter in the company’s evolution.
‘We are evolving into the type of next-generation growth partner that our clients will need in the future. Data-driven, embedded in industry and truly global,’ he said.
‘That type of ambition requires the right partner, hence why I am really looking forward to growing the business in partnership with the NorthEdge team over the coming years.’
Emma Banks, Managing Director of ramarketing added: “It’s a hugely exciting time for the global life sciences industry, and we are perfectly positioned to grow our market offering in line with the demand. Our HQ in Newcastle is part of a fast-growing life sciences hub serving a global market, with 86% of North East pharmaceutical production exported internationally, while our US base in Boston sits in the epicenter of the global life sciences corridor, so we have all the horsepower we need to support our clients across the world.’
She continued: ‘The support from NorthEdge will enable us to supercharge our creative, content and digital service offerings, while also investing in our diverse and talented team – providing genuine technical marketing expertise and deep sector knowledge, delivered the ramarketing way, across the life sciences industry.’
The investment was funded from NorthEdge’s £125 million SME Fund I and marks the private equity firm’s third deal in the life sciences sector over the last 18 months.
Liam May, Director at NorthEdge said: ‘The North East is a great place for investment, evidenced by an increasing volume of start-ups and a number of initiatives designed to turbo charge growth in the area – with health and life sciences being identified as a key growth sector for the region. ramarketing is a great example of a quality business based in the region that is shaping a global market, and we are excited to be a part of its journey.’
Ramarketing founder Raman Sehgal will lead a pharma marketing and strategy workshop at this year’s CPHI North America event – find out more here.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News On Track at Pharmapack 2024 - The Track Sponsor interview: BD Pharmaceuticals
January 2024 brings both a new year and Europe’s leading packaging and drug delivery event. Bringing the world’s experts in pharmaceutical packaging together in Paris, France, Pharmapack 2024 brings exciting opportunities to learn and colla... -
News CPHI Pharma Awards 2023 – API Development and Innovation Winners: Snapdragon Chemistry, a Cambrex Company
After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October. In this series of interviews, we speak to the teams behind the award-winning projects, concepts, and technologies. -
News PharmaKure gains authorisation for next stage testing on Alzheimer's treatment
Clinical stage pharmaceutical company PharmaKure gains permission from UK authorities to enter into further testing for PK051 for the treatment of patients with mild cognitive impairment associated with Alzheimer's disease. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News Navigating the Future: Challenges and Opportunities in Pharma Innovation and Investment – CPHI Barcelona 2023 Roundtable Report
In this comprehensive downloadable report, hear from a range of experts in finance and investment in the pharma industry on what investment trends will be shaping the future of the industry, in Catalonia, and the wider world. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance